Copy number gain of VCX, X-linked multi-copy gene, leads to cell proliferation and apoptosis during spermatogenesis

Oncotarget. 2016 Nov 29;7(48):78532-78540. doi: 10.18632/oncotarget.12397.

Abstract

Male factor infertility affects one-sixth of couples worldwide, and non-obstructive azoospermia (NOA) is one of the most severe forms. In recent years there has been increasing evidence to implicate the participation of X chromosome in the process of spermatogenesis. To uncover the roles of X-linked multi-copy genes in spermatogenesis, we performed systematic analysis of X-linked gene copy number variations (CNVs) and Y chromosome haplogrouping in 447 idiopathic NOA patients and 485 healthy controls. Interestingly, the frequency of individuals with abnormal level copy of Variable charge, X-linked (VCX) was significantly different between cases and controls after multiple test correction (p = 5.10 × 10-5). To discriminate the effect of gain/loss copies in these genes, we analyzed the frequency of X-linked multi-copy genes in subjects among subdivided groups. Our results demonstrated that individuals with increased copy numbers of Nuclear RNA export factor 2 (NXF2) (p = 9.21 × 10-8) and VCX (p = 1.97 × 10-4) conferred the risk of NOA. In vitro analysis demonstrated that increasing copy number of VCX could upregulate the gene expression and regulate cell proliferation and apoptosis. Our study establishes a robust association between the VCX CNVs and NOA risk.

Keywords: copy number variations; non-obstructive azoospermia.

MeSH terms

  • Adult
  • Apoptosis*
  • Azoospermia / genetics*
  • Azoospermia / pathology
  • Azoospermia / physiopathology
  • Case-Control Studies
  • Cell Cycle
  • Cell Proliferation*
  • Chromosomes, Human, X*
  • Chromosomes, Human, Y
  • DNA Copy Number Variations*
  • Fertility / genetics*
  • Gene Dosage*
  • Gene Expression Regulation, Developmental
  • Genetic Association Studies
  • Genetic Predisposition to Disease
  • Humans
  • Male
  • Nuclear Proteins / genetics*
  • Phenotype
  • Risk Factors
  • Spermatogenesis / genetics*
  • Spermatozoa / pathology*
  • Young Adult

Substances

  • Nuclear Proteins
  • VCX protein, human

Supplementary concepts

  • Azoospermia, Nonobstructive